Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yurong Lai

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 10, 2012
Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2): quantification by liquid chromatography/tandem mass spectrometryAnand K Deo, Bhagwat Prasad, Larissa Balogh, et al.
The Journal of Biological Chemistry|August 13, 2010
Regulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-{alpha}, IL-6, and IL-1{beta}Lei Diao, Na Li, Timothy G Brayman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 14, 2024
CYP7A1 Gene Induction via SHP-Dependent or Independent Mechanisms can Increase the Risk of Drug-Induced Liver Injury Independently or in Synergy with BSEP InhibitionCongrong Niu, Xiaodong Xie, Renmeng Liu, et al.
Chemical Research in Toxicology|February 19, 2016
Involvement of Drug Transporters in Organ Toxicity: The Fundamental Basis of Drug Discovery and DevelopmentYaofeng Cheng, Ayman El-Kattan, Yan Zhang, et al.
Rapid Communications in Mass Spectrometry : RCM|May 21, 2011
Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samplesYiqun Zhang, Na Li, Paul W Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 19, 2005
Changes in pharmacokinetics of anti-HIV protease inhibitors during pregnancy: the role of CYP3A and P-glycoproteinAnita A Mathias, Lillian Maggio-Price, Yurong Lai, et al.
Molecular Pharmaceutics|September 18, 2015
Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-GlucuronideEmi Kimoto, Rui Li, Renato J Scialis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 19, 2026
Mechanism-guided untargeted-to-targeted lipidomics identifies phosphatidylcholine 38:4 in rat bile as an Abcb4/Mdr2 inhibition markerRenmeng Liu, Zachary Rabow, Tingyuan Yang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 20, 2023
Assessing Pleiotropic Effects of a Mixed-Mode Perpetrator Drug, Rifampicin, by Multiple Endogenous Biomarkers in DogsRenmeng Liu, Bin Ma, Marilyn M Mok, et al.
The AAPS Journal|March 20, 2026
Physiologically Based Pharmacokinetic (PBPK) Modeling of Oral Drug Absorption for Integrating Nonclinical Data into Human Pharmacokinetic PredictionsXiaomin Liang, Grace Fraczkiewicz, Krutika Meena Harish Jain, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 10, 2012
Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2): quantification by liquid chromatography/tandem mass spectrometryAnand K Deo, Bhagwat Prasad, Larissa Balogh, et al.
The Journal of Biological Chemistry|August 13, 2010
Regulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-{alpha}, IL-6, and IL-1{beta}Lei Diao, Na Li, Timothy G Brayman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 14, 2024
CYP7A1 Gene Induction via SHP-Dependent or Independent Mechanisms can Increase the Risk of Drug-Induced Liver Injury Independently or in Synergy with BSEP InhibitionCongrong Niu, Xiaodong Xie, Renmeng Liu, et al.
Chemical Research in Toxicology|February 19, 2016
Involvement of Drug Transporters in Organ Toxicity: The Fundamental Basis of Drug Discovery and DevelopmentYaofeng Cheng, Ayman El-Kattan, Yan Zhang, et al.
Rapid Communications in Mass Spectrometry : RCM|May 21, 2011
Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samplesYiqun Zhang, Na Li, Paul W Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 19, 2005
Changes in pharmacokinetics of anti-HIV protease inhibitors during pregnancy: the role of CYP3A and P-glycoproteinAnita A Mathias, Lillian Maggio-Price, Yurong Lai, et al.
Molecular Pharmaceutics|September 18, 2015
Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-GlucuronideEmi Kimoto, Rui Li, Renato J Scialis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 19, 2026
Mechanism-guided untargeted-to-targeted lipidomics identifies phosphatidylcholine 38:4 in rat bile as an Abcb4/Mdr2 inhibition markerRenmeng Liu, Zachary Rabow, Tingyuan Yang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 20, 2023
Assessing Pleiotropic Effects of a Mixed-Mode Perpetrator Drug, Rifampicin, by Multiple Endogenous Biomarkers in DogsRenmeng Liu, Bin Ma, Marilyn M Mok, et al.
The AAPS Journal|March 20, 2026
Physiologically Based Pharmacokinetic (PBPK) Modeling of Oral Drug Absorption for Integrating Nonclinical Data into Human Pharmacokinetic PredictionsXiaomin Liang, Grace Fraczkiewicz, Krutika Meena Harish Jain, et al.
Pageof 14